Co-Diagnostics Net Profit Margin 2017-2025 | CODX

Co-Diagnostics net profit margin from 2017 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
Co-Diagnostics Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-03-31 $0.00B $-0.04B -925.00%
2024-12-31 $0.00B $-0.04B -950.00%
2024-09-30 $0.01B $-0.04B -525.00%
2024-06-30 $0.01B $-0.04B -422.22%
2024-03-31 $0.01B $-0.04B -650.00%
2023-12-31 $0.01B $-0.04B -514.29%
2023-09-30 $0.00B $-0.04B -1075.00%
2023-06-30 $0.01B $-0.04B -542.86%
2023-03-31 $0.01B $-0.03B -266.67%
2022-12-31 $0.03B $-0.01B -41.18%
2022-09-30 $0.05B $0.02B 28.30%
2022-06-30 $0.08B $0.03B 34.62%
2022-03-31 $0.10B $0.04B 40.00%
2021-12-31 $0.10B $0.04B 37.11%
2021-09-30 $0.10B $0.04B 40.38%
2021-06-30 $0.10B $0.05B 48.96%
2021-03-31 $0.09B $0.05B 55.91%
2020-12-31 $0.08B $0.04B 57.33%
2020-09-30 $0.05B $0.03B 58.33%
2020-06-30 $0.03B $0.01B 38.46%
2020-03-31 $0.00B $-0.01B -300.00%
2019-12-31 $0.00B $-0.01B 0.00%
2019-09-30 $0.00B $-0.01B 0.00%
2019-06-30 $0.00B $-0.01B 0.00%
2019-03-31 $0.00B $-0.01B 0.00%
2018-12-31 $0.00B $-0.01B 0.00%
2018-09-30 $0.00B $-0.01B 0.00%
2018-06-30 $0.00B $-0.01B 0.00%
2018-03-31 $0.00B $-0.01B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Services $0.010B $0.004B
Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $146.512B 27.48
Elevance Health (ELV) United States $86.065B 11.11
CVS Health (CVS) United States $83.137B 10.33
Cencora (COR) United States $55.558B 19.33
DiDi Global (DIDIY) China $23.015B 24.45
Natera (NTRA) United States $22.771B 0.00
BioMerieux (BMXMF) France $16.981B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.266B 0.00
Solventum (SOLV) United States $12.874B 13.63
ICON (ICLR) Ireland $11.753B 10.93
CochLear (CHEOY) Australia $11.492B 0.00
Revvity (RVTY) United States $11.324B 19.49
Doximity (DOCS) United States $10.794B 49.97
Viatris (VTRS) United States $10.540B 3.62
Avantor (AVTR) United States $9.213B 13.39
HealthEquity (HQY) United States $9.042B 39.61
Medpace Holdings (MEDP) United States $8.689B 23.08
Sonic Healthcare (SKHHY) Australia $8.397B 0.00
Charles River Laboratories (CRL) United States $7.422B 14.54
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.425B 26.06
BrightSpring Health Services (BTSG) United States $3.848B 35.31
Sotera Health (SHC) United States $3.423B 19.45
Alignment Healthcare (ALHC) United States $3.055B 0.00
Surgery Partners (SGRY) United States $2.969B 38.62
Concentras Parent (CON) United States $2.811B 16.24
Organon (OGN) United States $2.620B 2.78
GeneDx Holdings (WGS) United States $2.006B 77.28
Ardent Health (ARDT) United States $1.908B 8.13
Progyny (PGNY) United States $1.859B 40.92
Premier (PINC) United States $1.853B 14.06
GoodRx Holdings (GDRX) United States $1.618B 32.36
PACS (PACS) United States $1.615B 0.00
Teladoc Health (TDOC) United States $1.302B 0.00
Pediatrix Medical (MD) United States $1.222B 9.29
CareDx (CDNA) United States $1.118B 17.46
Establishment Labs Holdings (ESTA) $1.114B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.948B 0.00
AMN Healthcare Services Inc (AMN) United States $0.844B 7.90
QDM (QDMI) Hong Kong, SAR China $0.763B 0.00
Nutex Health (NUTX) United States $0.671B 10.16
Embecta (EMBC) United States $0.591B 3.98
LifeMD (LFMD) United States $0.574B 0.00
Enhabit (EHAB) United States $0.519B 42.71
InnovAge Holding (INNV) United States $0.514B 0.00
SBC Medicals (SBC) United States $0.481B 0.00
Sonida Senior Living (SNDA) United States $0.474B 0.00
Auna S.A (AUNA) Luxembourg $0.462B 10.40
COMPASS Pathways (CMPS) United Kingdom $0.429B 0.00
Oncology Institute (TOI) United States $0.255B 0.00
Performant Healthcare (PHLT) United States $0.252B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
DocGo (DCGO) United States $0.156B 25.50
KindlyMD (KDLY) United States $0.150B 0.00
KindlyMD (NAKA) United States $0.111B 0.00
Pheton Holdings (PTHL) China $0.109B 0.00
So-Young (SY) China $0.091B 0.00
Basel Medical Group (BMGL) Singapore $0.077B 0.00
OncoCyte (OCX) United States $0.076B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Ascend Wellness Holdings (AAWH) United States $0.058B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Sera Prognostics (SERA) United States $0.057B 0.00
ModivCare (MODV) United States $0.052B 0.00
OpGen (OPGN) United States $0.050B 0.00
Biodesix (BDSX) United States $0.047B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Intelligent Bio Solutions (INBS) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00